1. Diabetic Ketoacidosis as an Immune-related Adverse Event from Pembrolizumab in Non–Small Cell Lung Cancer. Issue 6 (July 2017) Authors: Leonardi, Giulia C.; Oxnard, Geoffrey R.; Haas, Andrea; Lang, Joshua P.; Williams, Jonathan S.; Awad, Mark M. Journal: Journal of immunotherapy Issue: Volume 40:Issue 6(2017:Jul./Aug.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗